This content is for informational purposes only and is not a substitute for professional advice.
Thesis is best reviewed as a set of public-facing nootropic formulas with quiz-guided routing, not as proof that a named capsule will improve focus, motivation, stress tolerance, memory, mood, ADHD, or any medical condition for a specific person. Start with a stack-risk audit: verify the current Supplement Facts panel for the exact product shipped, count caffeine from every source, screen medication and condition conflicts, and decide what result would justify continuing before the first dose.
This review is dated May 6, 2026. It uses public Thesis product pages, public Thesis help-center pages, and ingredient-level evidence sources. It does not use private company information, it is not sponsored, and it does not endorse Thesis products.
Disclosure
Unfair is our product. It is a supplement tracking and decision-support app for logging products, outcomes, side effects, and personal experiments. That commercial context matters, so the standard here is deliberately narrow.
This page does not claim Thesis treats ADHD, depression, anxiety disorders, dementia, traumatic brain injury, chronic fatigue, burnout, neurodegenerative disease, or any other medical condition. It also does not claim the products work. The question is whether a buyer can read the public label, understand the main evidence and risk questions, and run a disciplined self-test without confusing caffeine, expectation, normal day-to-day variability, or task pressure for product proof.
Methodology
| Criterion | What we checked | What still needs buyer verification |
|---|---|---|
| Public product set | Public pages for Clarity, Motivation, Stress Reset, and Neuroprotection were visible on May 6, 2026 | Whether the shipped products, labels, warnings, serving directions, and ingredient amounts match the pages |
| Caffeine exposure | A Thesis help page listed caffeine per capsule and a Thesis-specific daily cap | Total daily caffeine after coffee, tea, energy drinks, pre-workout, medications, and other supplements |
| Ingredient visibility | Product pages listed named ingredients; one Clarity help page listed two ingredient amounts | Full Supplement Facts amounts, extract markers, excipients, allergens, lot code, and expiration date |
| Evidence match | We compared public ingredient categories against human-evidence questions | Whether each bottle's exact form, amount, duration, and target outcome match the evidence a buyer may rely on |
| Testability | We assessed whether the products can be logged as separate whole-product trials | Whether the buyer can keep sleep, caffeine, diet, training, medications, and other nootropics stable enough to learn anything |
Product snapshot
Thesis public product pages observed on May 6, 2026 listed four named capsule products: Clarity, Motivation, Stress Reset, and Neuroprotection. Clarity, Stress Reset, and Neuroprotection showed with-caffeine and without-caffeine options; Motivation appeared as a caffeinated product in the public help-center caffeine table. clarity motivation stress-reset neuroprotection thesis-caffeine
A Thesis help page updated July 24, 2025 stated that one capsule of Motivation contains 75 mg caffeine and one capsule of Clarity, Stress Reset, or Neuroprotection contains 50 mg caffeine. The same page advised keeping total daily caffeine from Thesis formulas under 150 mg, starting with one formula for 3 to 5 days before adding another, checking ingredient lists before combinations, and spacing doses rather than taking multiple formulas at once. thesis-caffeine
Public pages also showed formula-change caveats. A Clarity help page updated May 12, 2025 described a newer Clarity formula and listed CDP citicoline at 250 mg and Panax ginseng at 200 mg. clarity-update Public product pages listed many ingredient names, but the visible page text did not consistently expose the complete Supplement Facts amounts for every ingredient observed here. That means the physical bottle or a current Supplement Facts panel is the source of record.
| Snapshot item | Public observation on May 6, 2026 | Conservative reading |
|---|---|---|
| Product category | Multiple named nootropic capsule formulas | Treat each formula as a separate whole-product experiment |
| Current public names | Clarity, Motivation, Stress Reset, Neuroprotection | Outcome names are marketing categories, not proof of personal response |
| Caffeine options | Clarity, Stress Reset, and Neuroprotection showed with-caffeine and without-caffeine selections | Caffeine-free versions are cleaner for attribution if they truly ship as selected |
| Public caffeine amounts | Motivation 75 mg per capsule; Clarity, Stress Reset, and Neuroprotection 50 mg per capsule; Thesis daily cap under 150 mg | Count this against all non-Thesis caffeine and stimulant exposure |
| Dose transparency | Clarity help content listed CDP citicoline 250 mg and Panax ginseng 200 mg; other visible page text did not consistently show all amounts | Do not evidence-match a formula until the full shipped label is captured |
| Testing claims | Public pages described microbial, active-ingredient, heavy-metal, and pesticide testing | Ask whether lot-specific certificates are available before relying on the claim |
| Consumer data | Product and science pages described open-label consumer perception studies and compensated feedback | Open-label, self-reported consumer data are not the same as blinded finished-product efficacy trials |
Personalization and quiz limitations
Thesis markets a quiz that routes users toward formulas. The conservative read is that an online questionnaire selecting from a limited product set is not personalized medicine, pharmacogenomic testing, clinician-guided prescribing, or proof that a formula matches the user's biology. It may be a useful shopping interface, but it cannot independently control for sleep debt, caffeine tolerance, anxiety sensitivity, medication exposure, placebo expectation, or the user's prior response to the same ingredients.
Quiz output also does not settle safety. A recommendation for a caffeinated formula does not mean the user's total stimulant exposure is appropriate. A recommendation for a calm- or stress-oriented formula does not mean it is compatible with antidepressants, sedatives, bipolar disorder history, pregnancy, liver disease, or a complex supplement stack. The buyer still needs label verification and, when relevant, clinician or pharmacist review.
For n-of-1 testing, the quiz result should be treated as a hypothesis: "This formula may be worth testing under controlled conditions." It should not be treated as a diagnosis, a personalized dose calculation, or a reason to skip baseline tracking.
Ingredient and evidence table
This table covers the ingredients and ingredient categories most relevant to public-label analysis. It does not confirm every amount. When amount, extract ratio, marker compound, plant part, or branded material is not visible in public text, the buyer should mark the evidence match as incomplete until the bottle is verified.
| Ingredient or category | Public observation | Evidence question | Testability issue |
|---|---|---|---|
| Caffeine | Thesis help page listed 75 mg per Motivation capsule and 50 mg per capsule for Clarity, Stress Reset, and Neuroprotection | Is the user responding to caffeine rather than the rest of the product? fda-caffeine | Caffeine can change alertness, anxiety, heart rate, sleep latency, and next-day scores |
| L-theanine | Motivation, Stress Reset, and Neuroprotection pages listed Camellia sinensis or L-theanine; Clarity page emphasized caffeine but not theanine in visible ingredient text | Does the formula behave differently from caffeine alone for the user's target outcome? theanine | Theanine may change caffeine feel, making the product seem smoother without proving broader cognitive benefit |
| CDP citicoline | Clarity help page listed CDP citicoline at 250 mg | Does the dose, population, and outcome match human citicoline literature? citicoline | Choline donors can cause headache, GI effects, mood change, or sleep effects that confuse focus ratings |
| Panax ginseng | Clarity product and help pages listed Panax ginseng; help page listed 200 mg | Is the extract standardized, and does it match human ginseng cognition or fatigue studies? ginseng | Ginseng can overlap with stimulant effects and deserves medication screening |
| Lion's Mane and 7,8-DHF | Clarity listed Hericium erinaceus and 7,8-dihydroxyflavone | Are these exact forms supported by human outcome data at the shipped amount? | Mechanistic or animal-model logic does not prove a workday effect in a mixed product |
| Dynamine and TeaCrine | Motivation listed methylliberine and theacrine branded ingredients | Is the main signal extended stimulant-like energy rather than motivation? | Attribution is hard if taken with coffee, poor sleep, or deadline pressure |
| N-acetyl-L-tyrosine and salidrosides | Motivation listed NALT and fermented salidrosides | Is the use case acute stress performance, fatigue, or daily drive? | Dopamine-adjacent narratives can encourage over-reading normal day-to-day motivation changes |
| Ashwagandha, saffron, kanna, honokiol, magnesium, vitamin D3 | Stress Reset listed these calm- or mood-adjacent ingredients | Are the extracts, doses, and medication contexts appropriate? ashwagandha | Sedation, emotional flattening, GI effects, sleep changes, and medication interactions can dominate the signal |
| Bacopa and ginkgo | Neuroprotection listed Bacopa monnieri and Ginkgo biloba | Does the label state standardization markers and support the intended time horizon? bacopa ginkgo | Bacopa often fits longer trials; ginkgo raises interaction questions for some users |
| Sulforaphane-pathway ingredients, turmeric, CoQ10, PQQ, NADH, spermidine, selenium | Neuroprotection listed mustard seed, broccoli seed, turmeric, CoQ10, PQQ, NADH, spermidine, and selenium | Is the target acute cognition, long-horizon health support, or correction of low intake? | Slow or indirect pathways are hard to detect in a short productivity trial |
The strict evidence rule is simple: match ingredient form, amount, duration, population, and outcome. If the public page does not show the exact amount and form, the evidence match is incomplete. If a study used a different extract, dose, participant group, or time horizon, treat it as background evidence rather than proof about the bottle in your hand.
Safety interactions and who should avoid
Caffeine is the easiest acute variable to understand and the easiest to undercount. The FDA has cited 400 mg caffeine per day as an amount not generally associated with dangerous negative effects for most healthy adults, with wide person-to-person sensitivity. fda-caffeine A Thesis-specific 50 to 75 mg capsule may still be too much for a caffeine-sensitive person, too late in the day for normal sleep, or too much when combined with coffee, tea, energy drinks, pre-workout, nicotine, ADHD medication, or other stimulants.
Medication screening matters across the product set. Ginseng can interact with blood-thinning medications, diabetes medications, and immunosuppressants. ginseng-safety Ginkgo can raise bleeding and seizure-threshold concerns in some contexts. ginkgo Ashwagandha has safety cautions around pregnancy, thyroid effects, sedation, liver injury reports, and medication use. ashwagandha Kanna, saffron, tyrosine-family ingredients, honokiol, cholinergic ingredients, and stimulant-like compounds deserve extra caution with psychiatric medication, stimulant medication, thyroid medication, blood-pressure medication, sedatives, migraine drugs, seizure history, and complex supplement stacks.
Avoid unsupervised Thesis testing if you are pregnant, breastfeeding, under 18, trying to conceive, managing bipolar disorder, psychosis risk, panic disorder, uncontrolled anxiety, uncontrolled hypertension, arrhythmia, seizure history, active liver disease, active kidney disease, bleeding disorder, upcoming surgery, or recent medication changes.
Also skip it if you cannot verify the exact shipped label, cannot tolerate caffeine and cannot confirm a caffeine-free version, are already using multiple nootropics, need clean attribution, or are looking for a product to manage ADHD, depression, anxiety, cognitive decline, traumatic brain injury, or another clinical problem.
Stop conditions should be written before the first serving. Reasonable stop conditions include palpitations, chest pain, faintness, severe anxiety, insomnia, unusual agitation, unusual mood elevation, rash, jaundice, dark urine, new bruising, severe headache, persistent GI distress, or any symptom that feels medically concerning.
Buyer quality checks
Before buying, capture the current Supplement Facts panel for the exact formula and caffeine selection. A clean buyer record should include product name, formula name, caffeine or caffeine-free version, serving size, servings per container, full ingredient amounts, other ingredients, allergen statements, warnings, directions, lot number, expiration date, purchase channel, subscription terms, and refund terms.
Do not rely on product names alone. Formula names can stay the same while ingredients, amounts, serving directions, and claims change. Thesis help pages explicitly discuss formula updates, and public product pages note that some claims come from prior formula versions or open-label consumer perception studies. clarity-update thesis-science
Ask whether Thesis provides lot-specific certificates of analysis or a testing record that covers identity, active-ingredient amount, heavy metals, microbial contamination, pesticides, and adulterants. Public product pages state that Thesis screens for microorganisms, verifies active ingredient amounts, screens for heavy metals, and tests raw materials for pesticide residues. clarity That is useful as a public quality claim, but a buyer-quality audit is stronger when the test result is tied to the actual lot shipped.
Use the FDA and FTC as guardrails. Dietary supplement labels need required information, and health-product advertising should be truthful, non-misleading, and supported by appropriate evidence. fda-label ftc Testimonials, star ratings, quiz recommendations, and open-label self-reported data should not outweigh a current label, a safety screen, and a sober trial design.
Unfair n-of-1 protocol
Log Thesis at the whole-product level first. Create separate product entries for Clarity, Motivation, Stress Reset, and Neuroprotection if you test more than one formula. Do not collapse them into "Thesis" as a single exposure, and do not split them into ingredients unless the exact shipped label lists all amounts and forms.
| Phase | Duration | Action | What to record |
|---|---|---|---|
| Label capture | 1 day | Photograph the Supplement Facts panel, directions, warnings, caffeine selection, lot, and expiration date | Formula name, version, caffeine amount, serving size, purchase date, label photos |
| Baseline | 7-14 days | Keep caffeine, sleep schedule, training, diet, medications, and other supplements stable | Focus rating, deep-work minutes, task output, sleep, mood, anxiety, heart rate if available, headache, GI effects |
| First exposure | 1 day | Use the smallest practical serving allowed by the label early in the day | Dose time, food status, total caffeine, acute effects, side effects, sleep that night |
| Trial | 14-30 days | Test one Thesis formula only; avoid new supplements and dose changes | Same daily outcomes plus missed doses, stressful events, alcohol, illness, and schedule changes |
| Washout | 7-14 days | Stop the formula and keep tracking | Whether benefits, side effects, sleep, mood, or anxiety return toward baseline |
| Decision | 1 day | Compare baseline, trial, and washout against a prewritten rule | Continue, reject, retest, or replace with simpler single-ingredient trials |
A useful decision rule is specific and modest. For example: continue only if deep-work minutes or task completion improves meaningfully during the trial, returns toward baseline after washout, and does not come with worse sleep, anxiety, heart rate, irritability, headache, or next-day fatigue.
If the main signal is "I felt stimulated," record it as a caffeine or stimulant response, not broad product proof. If the main signal appears only on deadline days, poor-sleep days, or days with extra coffee, mark the result as confounded. If you want to test a second Thesis formula, finish the washout and restart with a new baseline.
Bottom line
Thesis is more complicated than a single nootropic product because it pairs a quiz-guided shopping flow with multiple named formulas, caffeine variants, formula-update history, and public pages that do not always expose every Supplement Facts amount in visible text. That does not make it useless, and it does not make it proven. It makes bottle verification and disciplined testing the whole game.
The conservative buyer decision is to verify the exact label, demand current dose clarity, count caffeine carefully, screen medication and condition risks, test one formula at a time, and keep attribution expectations realistic. If your goal is a clean signal, start with simpler ingredients before attempting a multi-ingredient branded formula.
Sources
This article is for education only and does not replace medical advice.
Thesis. Clarity product page, accessed May 6, 2026. https://takethesis.com/products/clarity
↩Thesis. Motivation product page, accessed May 6, 2026. https://takethesis.com/products/motivation
↩Thesis. Stress Reset product page, accessed May 6, 2026. https://takethesis.com/products/stress-reset
↩Thesis. Neuroprotection product page, accessed May 6, 2026. https://takethesis.com/products/neuroprotection
↩Thesis Help Center. Can I take multiple formulas at the same time? Updated July 24, 2025; accessed May 6, 2026. https://takethesis.zendesk.com/hc/en-us/articles/38158215340941-Can-I-take-multiple-formulas-at-the-same-time
↩Thesis Help Center. Is the new Clarity the same as the Clarity I currently receive from Thesis? Updated May 12, 2025; accessed May 6, 2026. https://takethesis.zendesk.com/hc/en-us/articles/36463518503949-Is-the-new-Clarity-the-same-as-the-Clarity-I-currently-receive-from-Thesis
↩Thesis. Science page, accessed May 6, 2026. https://takethesis.com/science
↩U.S. Food and Drug Administration. Spilling the Beans: How Much Caffeine is Too Much? https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much
↩U.S. Food and Drug Administration. Dietary Supplement Labeling Guide. https://www.fda.gov/food/dietary-supplements/dietary-supplement-labeling-guide
↩Federal Trade Commission. Health Products Compliance Guidance. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
↩Hidese S, Ogawa S, Ota M, et al. Effects of L-Theanine administration on stress-related symptoms and cognitive functions in healthy adults. https://pmc.ncbi.nlm.nih.gov/articles/PMC6836118/
↩Nakazaki E, Mah E, Sanoshy K, et al. Citicoline and memory function in healthy older adults. https://pmc.ncbi.nlm.nih.gov/articles/PMC8349115/
↩Reay JL, Kennedy DO, Scholey AB. Single doses of Panax ginseng and cognitive performance during sustained mental activity. https://pubmed.ncbi.nlm.nih.gov/15982990/
↩NIH NCCIH. Asian Ginseng. https://www.nccih.nih.gov/health/asian-ginseng
↩NIH Office of Dietary Supplements. Ashwagandha: Is it helpful for stress, anxiety, or sleep? https://ods.od.nih.gov/factsheets/Ashwagandha-HealthProfessional/
↩Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N, Scholfield CN. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. https://pubmed.ncbi.nlm.nih.gov/24252493/
↩NIH NCCIH. Ginkgo. https://www.nccih.nih.gov/health/ginkgo
↩